Cystic fibrosis foundation funds up to $15 million to prime medicine to pursue gene editing in cf

Bethesda, md.--(business wire)--today, the cystic fibrosis foundation announced that it will provide up to $15 million to prime medicine for preclinical research into gene editing for cystic fibrosis. prime medicine is using a gene editing technology called prime editing — a technology that enables insertions or deletions of small segments of dna at precise sites. prime medicine — founded by researchers who pioneered the development of this unique editing technology — is investigating whether p.
PRME Ratings Summary
PRME Quant Ranking